Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin

Showing results (571-580 of 692) with videos related to

Pageof 70
Sort By:
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Human Reproduction (Oxford, England)|August 17, 2025
Paracetamol (N-acetyl-para-aminophenol) disrupts early embryogenesis by cell cycle inhibitionBrian S Nielsen, Morten R Petersen, Javier Martin-Gonzalez, et al.
Cancer Communications (London, England)|March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma CohortJavier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Annals of Surgical Oncology|April 17, 2026
First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
European Geriatric Medicine|November 21, 2020
A European Research Agenda for Geriatric Emergency Medicine: a modified Delphi studySimon P Mooijaart, Christian H Nickel, Simon P Conroy, et al.
Inflammatory Bowel Diseases|December 31, 2013
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD groupLissy de Ridder, Dan Turner, David C Wilson, et al.
The Lancet. Oncology|May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Arthritis Research & Therapy|June 27, 2012
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosisMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Pageof 70

Showing results (571-580 of 692) with videos related to

Sort By:
Pageof 70
JAMA Network Open|November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical TrialSandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Human Reproduction (Oxford, England)|August 17, 2025
Paracetamol (N-acetyl-para-aminophenol) disrupts early embryogenesis by cell cycle inhibitionBrian S Nielsen, Morten R Petersen, Javier Martin-Gonzalez, et al.
Cancer Communications (London, England)|March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma CohortJavier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Annals of Surgical Oncology|April 17, 2026
First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
European Geriatric Medicine|November 21, 2020
A European Research Agenda for Geriatric Emergency Medicine: a modified Delphi studySimon P Mooijaart, Christian H Nickel, Simon P Conroy, et al.
Inflammatory Bowel Diseases|December 31, 2013
Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD groupLissy de Ridder, Dan Turner, David C Wilson, et al.
The Lancet. Oncology|May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Arthritis Research & Therapy|June 27, 2012
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosisMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Pageof 70